PUBLICATIONS · 11956258
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Apr 15
- First author
- Ross P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2002 Apr 15;20(8):1962-4. doi: 10.1200/JCO.2002.20.8.1962.
- note
- Source null
- related pmid
- 11956251
- relationship
- Comment in
- citation
- J Clin Oncol. 2002 Oct 1;20(19):4124-5; author reply 4125-6. doi: 10.1200/JCO.2002.99.125.
- note
- Source null
- related pmid
- 12351613
- relationship
- Comment in
Authors and identifiers
- name
- Ross P
- type
- Author
- name
- Nicolson M
- type
- Author
- name
- Cunningham D
- type
- Author
- name
- Valle J
- type
- Author
- name
- Seymour M
- type
- Author
- name
- Harper P
- type
- Author
- name
- Price T
- type
- Author
- name
- Anderson H
- type
- Author
- name
- Iveson T
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Lofts F
- type
- Author
- name
- Norman A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ross P
- type
- Author
- name
- Nicolson M
- type
- Author
- name
- Cunningham D
- type
- Author
- name
- Valle J
- type
- Author
- name
- Seymour M
- type
- Author
- name
- Harper P
- type
- Author
- name
- Price T
- type
- Author
- name
- Anderson H
- type
- Author
- name
- Iveson T
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Lofts F
- type
- Author
- name
- Norman A
- type
- Author
- bibliography ids
- nci-bib-7298483890dd419819b9f3a7
- book metadata
- content sha256
- e14ac8f092724c79a6c6940b41292e3c14208626b8601f7d1fe578a90b57c05a
- document type
- citation
- dois
- 10.1200/JCO.2002.08.105
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11956258
- immutable id
- pubmed:11956258@e14ac8f092724c79a6c6940b41292e3c14208626b8601f7d1fe578a90b57c05a
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1996-2004
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2002 Apr 15;20(8):1962-4. doi: 10.1200/JCO.2002.20.8.1962.
- note
- Source null
- related pmid
- 11956251
- relationship
- Comment in
- citation
- J Clin Oncol. 2002 Oct 1;20(19):4124-5; author reply 4125-6. doi: 10.1200/JCO.2002.99.125.
- note
- Source null
- related pmid
- 12351613
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 11956258
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- 07e114ba84143f38bb53a49069c7f7a56afc7c7c95a48fc80c50a7e4a72f5b74
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2002 Apr 15
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Preserved source evidence · Not medical advice
Triangle